VICE PRESIDENT, RESEARCH AND NONCLINICAL DEVELOPMENT
Joel Kaye, PhD, joins Ayala with extensive experience in pharmacology and drug development. Prior to Ayala, Joel held various leadership positions at the Global R&D, Teva Pharmaceutical (NYSE: TEVA), focusing on nonclinical and pharmacological development of numerous products. In his last role, Joel was a Director at the Pharmacology Department, Discovery & Product Development and was the head of Cancer Pharmacology and new model development. Joel’s experience in drug development extends across the clinical development pathway, from discovery to Phase 3 and post-marketing life cycle management. Joel is an inventor or co-inventor of 13 patents and has published 20 articles. Joel did his Post-Doctoral Fellowship at Massachusetts General Hospital and Harvard Medical School and has a PhD in Immunology from the Weizmann Institute of Science, Israel.